about
Clinical use of proteasome inhibitors in the treatment of multiple myelomaAdvances in pharmacotherapy to treat kidney transplant rejection.Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.An Overview of Bortezomib-Induced NeurotoxicityLncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma.
P2860
Q28080999-DB4787AB-16F3-4211-B147-90DC8F393733Q38544529-176BD715-FDB6-43BE-8715-49A99B3EBB27Q38776733-B9D45328-F6EF-441A-8C2C-9CFF5647ADDCQ38847744-AD03EECD-74BE-4CE4-9D99-C2CC56122785Q41253617-2CFB0C9A-4474-4A64-B602-E6C744466CA2Q42361419-C383BDC8-A70A-4E42-A657-3F08E97142E4Q48125035-A1B551F3-7538-4DFB-9E4E-35DD8D54E4AF
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Bortezomib for the treatment of multiple myeloma.
@en
Bortezomib for the treatment of multiple myeloma.
@nl
type
label
Bortezomib for the treatment of multiple myeloma.
@en
Bortezomib for the treatment of multiple myeloma.
@nl
prefLabel
Bortezomib for the treatment of multiple myeloma.
@en
Bortezomib for the treatment of multiple myeloma.
@nl
P2860
P1476
Bortezomib for the treatment of multiple myeloma
@en
P2093
Agnieszka Barchnicka
Anida Grosicka
P2860
P304
P356
10.1586/17474086.2014.899144
P577
2014-04-01T00:00:00Z